NO20082503L - Fremgangsmate for fremstilling av olanzapin - Google Patents

Fremgangsmate for fremstilling av olanzapin

Info

Publication number
NO20082503L
NO20082503L NO20082503A NO20082503A NO20082503L NO 20082503 L NO20082503 L NO 20082503L NO 20082503 A NO20082503 A NO 20082503A NO 20082503 A NO20082503 A NO 20082503A NO 20082503 L NO20082503 L NO 20082503L
Authority
NO
Norway
Prior art keywords
preparation
thieno
methyl
formula
benzodiazepine
Prior art date
Application number
NO20082503A
Other languages
English (en)
Inventor
Kalman Nagy
Norbert Mesterhazy
Gyorgy Krasznai
Zsuzsanna Szent-Kirallyi
Gyorgyi Kovanyine Lax
Gabor Nemeth
Gyorgy Vereczkeyne Donath
Original Assignee
Egis Gyogyszergyar Nyilvanosan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyogyszergyar Nyilvanosan filed Critical Egis Gyogyszergyar Nyilvanosan
Publication of NO20082503L publication Critical patent/NO20082503L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Foreliggende oppfinnelse angår en fremgangsmåte for fremstilling av 2-metyl-4-(4-metylpiperazin-l-yl)-10H-tieno-[2,3-b] [l,5]benzodiazepin (olanzapin) med formel (I) ved omsetting av 4-amino-2-metyl-10H-tieno[2,3-b] [l,5]benzodiazepin hydroklorid med formel (II) med N-metylpiperazin i et organisk løsemiddel, som innbefatter utføring av reaksjonen i blanding av toluen og l,3-dimetyl-2-imidazolidinon. Oppfinnelsen omfatter også ny 2-metyl-4-(4-metylpiperazin-l-yl)-10H-tieno-[2,3-b] [l,5]benzodiazepin dihydrokloridtrihydrat med formel (IB), fremstilling derav og farmasøytiske sammensetninger som innbefatter nevnte nye forbindelse.
NO20082503A 2005-11-11 2008-06-03 Fremgangsmate for fremstilling av olanzapin NO20082503L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0501046A HUP0501046A2 (en) 2005-11-11 2005-11-11 Process for the preparation of olanzapine
PCT/HU2006/000096 WO2007054750A2 (en) 2005-11-11 2006-11-10 Process for the preparation of olanzapine

Publications (1)

Publication Number Publication Date
NO20082503L true NO20082503L (no) 2008-08-11

Family

ID=89986394

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20082503A NO20082503L (no) 2005-11-11 2008-06-03 Fremgangsmate for fremstilling av olanzapin

Country Status (13)

Country Link
US (1) US7981884B2 (no)
EP (2) EP1963335B1 (no)
JP (1) JP2009515867A (no)
CN (1) CN101400683A (no)
AT (1) ATE508131T1 (no)
DE (1) DE602006021792D1 (no)
EA (2) EA201001278A1 (no)
HU (1) HUP0501046A2 (no)
NO (1) NO20082503L (no)
PL (1) PL1963335T3 (no)
SI (1) SI1963335T1 (no)
UA (1) UA93527C2 (no)
WO (1) WO2007054750A2 (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102924472B (zh) * 2012-09-03 2013-06-05 江苏豪森药业股份有限公司 一种奥氮平的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
US5631250A (en) 1995-03-24 1997-05-20 Eli Lilly And Company Process and solvate of 2-methyl-thieno-benzodiazepine
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
CZ2003566A3 (cs) * 2000-08-31 2004-01-14 Dr. Reddy's Laboratories Ltd. Způsob přípravy hydrátů olanzapinu a jejich konverze na krystalické formy olanzapinu
US7297789B2 (en) 2002-05-31 2007-11-20 Sandoz, Inc. Process of preparation of olanzapine form I
HU226410B1 (en) 2003-04-22 2008-11-28 Egis Gyogyszergyar Nyilvanosan Novel polymorphous forms of olanzapine hydrochlorides, process for producing them, use thereof and pharmaceutical compositions containing them
ATE397611T1 (de) * 2003-12-22 2008-06-15 Teva Pharma Verfahren zur herstellung von olanzapin

Also Published As

Publication number Publication date
HUP0501046A2 (en) 2007-08-28
US20090137563A1 (en) 2009-05-28
SI1963335T1 (sl) 2011-10-28
WO2007054750A3 (en) 2007-10-11
ATE508131T1 (de) 2011-05-15
CN101400683A (zh) 2009-04-01
EA200801043A1 (ru) 2008-10-30
DE602006021792D1 (de) 2011-06-16
UA93527C2 (en) 2011-02-25
EP1963335A2 (en) 2008-09-03
EP1997822A1 (en) 2008-12-03
JP2009515867A (ja) 2009-04-16
PL1963335T3 (pl) 2011-12-30
WO2007054750A2 (en) 2007-05-18
EA201001278A1 (ru) 2011-02-28
HU0501046D0 (en) 2006-01-30
EP1963335B1 (en) 2011-05-04
US7981884B2 (en) 2011-07-19
EA014934B1 (ru) 2011-04-29

Similar Documents

Publication Publication Date Title
TW200613274A (en) Organic compounds
WO2006024486A3 (en) Amide derivatives of 3-phenyl dihydropyrimido[4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents
ATE384061T1 (de) Imidazo- und thiazolopyridine als jak3-kinase- inhibitoren
SE0104140D0 (sv) Novel Compounds
ATE485300T1 (de) Als aurora-kinase-inhibitoren nutzbare thienopyrimidine
NO20060324L (no) [1,8]Naftyridin-2-oner og relaterte forbindelser for behandling av Schizofreni
TW200801003A (en) Novel compounds
TW200616995A (en) Novel compounds
TW200635917A (en) Novel compounds
CY1109962T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας
TW200605888A (en) Novel compounds
MX2007007025A (es) Nuevos derivados de hidantoina como inhibidores de metaloproteinasa.
JO2616B1 (ar) مركبات ثلاثية الحلقات جديدة، طريقة من أجل تحضيرها ومركباتها الصيدلانية
SE0400850D0 (sv) Novel Compounds
NO20070550L (no) Fremgangsmate for fremstilling av pyrrolotriazinforbindelser
BR0318521A (pt) arilindenopiridinas e arilindenopirimidinas e métodos terapêuticos e profiláticos relacionados
ATE401332T1 (de) Neue polymorphe von olanzapin-hydrochlorid
NO20082503L (no) Fremgangsmate for fremstilling av olanzapin
DK1501838T3 (da) Fremgangsmåde til fremstilling af clopidogrel
WO2010007248A3 (fr) Nouveaux derives tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
Suzuki et al. Synthesis and muscarinic activity of novel aniline derivatives with a 1-azabicyclo [3.3. 0] octane moiety
EA200601248A1 (ru) Новые многократно замещённые соединения 1,1-пиридилоксициклопропанамина, способ их получения и фармацевтические композиции, которые их содержат
SE0400440D0 (sv) Novel Cinnamic Amides
TH101953A (th) อนุพันธ์ 1H-ไทอีโน[2,3-c] ไพแรซอล ที่มีประโยชน์เป็นสารยับยั้งไคเนส

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application